WHO
REGULATORY UPDATE
Active Pharmaceutical Ingredient (API) Prequalified
Published: 10/27/2026Detected: 9/18/2026
Summary preview
Prequalifies lamivudine API from Jiangxi Desano Pharmaceutical Co. Ltd. under WHO’s API prequalification program, enabling manufacturers of HIV/AIDS finished pharmaceutical products (FPPs) to use this specifically…
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountinfectious_disease
manufacturing
quality
#WHO prequalification
#API prequalification
#APIMF
#WHO GMP
#lamivudine
Official Source Document Source Verified
Access the original document directly from WHO.